Company Info
Phone(617) 916-5445
Year Established
2023
Ticker
CADL
Exchange
NASDAQ
Contacts
Paul Peter Tak, MD, PhD, FMedSciPresident & CEO
Charles Schoch
Interim CFO
Francesca Barone, M.D., Ph.D.
CSO
Seshu Tyagarajan, Ph.D., RAC
CTO & CDO
W. Garrett Nichols, M.D., M.S.
CMO
Company Description
Candel is a clinical stage biopharmaceutical company focused on developing and commercializing viral immunotherapies that elicit a systemic anti-tumor immune response to help patients fight cancer.
